AI Issues: Anthropic Launches Claude for Life Sciences
Anthropic has unveiled Claude for Life Sciences.
Key Points
Anthropic has released Claude for Life Sciences, focused on accelerating life sciences research and advancement.
The company's latest model, Claude Sonnet 4.5, has demonstrated capabilities exceeding human baselines in Protocol QA and BixBench benchmarks.
New connectors link Claude to Benchling, BioRender, PubMed, Wiley Scholar Gateway, Synapse.org, and 10x Genomics.
Through agentic skills, Claude can follow consistent scientific procedures and autonomously perform complex data analysis.
Initial partners include Sanofi, Deloitte, KPMG, Accenture, PwC, AWS, and Google Cloud.
Anthropic Builds AI Tools for Scientific Advancement
Anthropic says its public benefit mission is to accelerate scientific advancement by creating AI systems that help with research discoveries and ultimately contribute autonomously.
Until recently, scientists mainly used Claude for individual tasks like writing statistical code or summarizing academic papers.
Now the company's goal is to make Claude a partner across the entire research pipeline, from generating hypotheses to actual product launches.
"Accelerating scientific advancement is core to our mission."
Anthropic stated in its announcement.
"We are focused on building tools that enable researchers to make new discoveries, and ultimately on enabling AI models to make those discoveries themselves."
Enhanced Performance of Claude Sonnet 4.5
At the heart of the upgrade is Claude Sonnet 4.5, the most advanced Anthropic model to date.
This model shows significantly improved results on life sciences benchmarks compared to previous versions.
On Protocol QA, which tests AI model understanding and reasoning across laboratory procedures and experimental methods, Claude Sonnet 4.5 scored 0.83.
This exceeds the human baseline of 0.79 and Sonnet 4's score of 0.74.
BixBench, which measures bioinformatics task performance, showed similar results with improved comprehension and accuracy.
These advances make Claude a more reliable collaboration partner for complex laboratory, clinical, and regulatory tasks, according to Anthropic.
New Connectors for Scientific Platforms
Anthropic is expanding Claude's ecosystem with life sciences-specific support in the form of new connectors to scientific platforms, agentic skills capabilities, a prompt library, and dedicated support.
This update directly connects Claude with key research tools, making it easy for scientists to access systems they already use.
Benchling - Provides the ability to answer scientists' questions with direct links to experimental data, notes, and lab records, ensuring traceability and reproducibility.
BioRender - Connects Claude to a vast library of verified scientific illustrations, icons, and templates, enabling accurate visual and figure generation.
PubMed - Provides Claude access to millions of biomedical research papers and clinical studies, enabling citations, summaries, and contextual literature reviews.
Scholar Gateway (developed by Wiley) - Integrates peer-reviewed scientific content within Claude to accelerate discovery of reliable research materials.
Synapse.org - Enables data sharing and collaborative analysis for research teams, supporting both public and private projects through Claude's interface.
10x Genomics - Allows researchers to perform single-cell and spatial transcriptomics analysis using natural language, expanding Claude's role in bioinformatics and genomics workflows.
These new scientific connectors build on existing connections with enterprise and data platforms, broadening utility for bioinformatics, collaborative research, and enterprise-scale analysis.
Google Workspace - Enables Claude to create, edit, and summarize content in Docs, Sheets, and Slides, and coordinate updates through Gmail and Calendar.
Microsoft 365 - Connects to SharePoint, OneDrive, Outlook, and Teams, enabling secure document management, team collaboration, and communication automation directly through Claude.
Databricks - Enables Claude to perform analysis and modeling on large-scale bioinformatics data, helping researchers visualize trends and run exploratory queries using natural language.
Snowflake - Enables Claude to conversationally search, query, and analyze large-scale data, connecting structured data with scientific context for deeper insights.
Through these connections, researchers and enterprise teams can embed Claude's reasoning capabilities directly into data pipelines and collaboration tools, creating a more integrated environment for scientific discovery and analysis.
Agentic Skills for Scientific Workflows
Anthropic also introduced agentic skills — structured folders of instructions, scripts, and resources that enhance Claude's ability to perform repeatable tasks.
The company showcased the scRNA-qc skill as its first example, which analyzes single-cell RNA sequencing data using scverse best practices.
Scientists can also create custom skills to store their own lab procedures and data workflows directly in Claude's memory.
Practical Applications Across Life Sciences
Anthropic describes a broad range of use cases where Claude can help scientific and commercial teams:
Research and Literature Review: Summarize biomedical research, identify knowledge gaps, and generate testable hypotheses.
Protocol Generation: Draft research protocols, standard operating procedures (SOPs), and consent forms, and cross-reference through the Benchling connector.
Bioinformatics and Data Analysis: Process and analyze genomic data with Claude Code, generating results in notes, slides, or document formats.
Clinical and Regulatory Compliance: Draft and review regulatory submissions and gather compliance data for audits.
To accelerate adoption, Anthropic has tailored a prompt library for common scientific tasks, helping researchers get accurate results faster.
Partnerships, Customers, and Industry Adoption
Anthropic is partnering with consulting and technology leaders to bring AI-powered discovery into mainstream life sciences workflows.
Partners include Caylent, Deloitte, Accenture, KPMG, PwC, Quantium, Slalom, Tribe AI, and Turing, along with AWS and Google Cloud.
Leading pharmaceutical company Sanofi is already using Claude internally.
Sanofi's Chief Digital Officer Emmanuel Frenehard said:
"Claude combined with our internal knowledge libraries is an essential element of Sanofi's AI transformation and is used daily by most Sanofi employees through our concierge app."
"We are seeing efficiency improvements across the value chain, and the enterprise-wide deployment has improved how teams work. This collaboration with Anthropic enhances human expertise to help deliver life-changing medicines to patients worldwide faster."
AI for Science Program and Research Support
Anthropic continues to support fundamental research through its AI for Science program beyond commercial products.
This program provides free API credits to leading labs and researchers solving high-impact scientific problems.
These collaborations not only accelerate academic advancement but also help identify new opportunities to leverage Claude's reasoning capabilities in the scientific domain.
The company encourages researchers to continue submitting new project ideas through the AI for Science program, proposing high-impact research that leverages Claude's discovery tools.
In the overview video below, Jonah Cool and Eric Kauderer-Abrams, who lead Anthropic's life sciences partnerships and R&D, explain Claude for Life Sciences and other recent programs, providing deep insights into how the company is advancing AI-assisted research.
Availability
Claude for Life Sciences is currently available through Claude.com and AWS Marketplace, with Google Cloud Marketplace support coming soon.
Researchers and organizations can request a live demo or apply for early integration support directly through Anthropic.
Q&A
| Question | Answer |
|---|---|
| Q1: What is Claude for Life Sciences? | An enhanced version of Anthropic's Claude AI tailored for biomedical and research workflows, from literature review to regulatory compliance. |
| Q2: What differentiates Claude Sonnet 4.5? | It delivers high accuracy that exceeds human baseline performance on scientific benchmarks like Protocol QA and BixBench. |
| Q3: What are "connectors" and how do they help? | Connectors enable Claude to interact directly with scientific platforms like Benchling, BioRender, and PubMed, producing contextual, source-linked outputs. |
| Q4: How do agentic skills improve performance? | Agentic skills train Claude to follow precise scientific procedures, ensuring consistency and protocol adherence across tasks. |
| Q5: How can scientists access it? | Claude for Life Sciences is accessible through Claude.com and AWS Marketplace, with Google Cloud support coming soon. |
Implications
Anthropic's Claude for Life Sciences signals a major shift in how AI systems can contribute to real scientific discovery.
By embedding Claude directly into labs and research workflows, Anthropic is bridging the critical gap between computational reasoning and experimental validation — a challenge that has historically slowed progress in the biomedical field.
The potential impact extends far beyond productivity.
As life sciences grow increasingly complex, AI models like Claude Sonnet 4.5 can help researchers navigate large-scale data, interpret ambiguous results, and identify promising paths for new therapies or technologies.
This could dramatically accelerate drug development, genomic research, and biotechnology advances while reducing the time and cost needed to bring discoveries from concept to clinic.
Equally important is that Claude's transparent integration and skills-based architecture provide a responsible blueprint for scientific AI — one where humans maintain control over design and oversight while machines handle the complexity of scale and data analysis.
Practically, this shift positions Anthropic not merely as a model developer but as a partner in AI-augmented science, changing how labs, pharma companies, and research institutions approach discovery.
If the system works as intended, Claude for Life Sciences could become the foundational layer of next-generation AI-powered R&D infrastructure, helping scientists answer deeper questions faster and ultimately accelerating advances to improve global health outcomes.
IMPAKERS Blog | The Emergence of Decentralized AI Networks Read more
Source: Alicia Shapiro, AiNews, "Anthropic launches Claude for Life Sciences with new AI tools", https://www.ainews.com/p/anthropic-launches-claude-for-life-sciences-with-new-ai-tools, (2025-10-22)